BioDiem buys Savine Therapeutics
15 December, 2011 by Dylan Bushell-EmblingVaccine company BioDiem (ASX:BDM) has added antigen development technology to its portfolio with the purchase of Savine Therapeutics.
IQnovate completes public listing on NSX
15 December, 2011 by Dylan Bushell-EmblingShares in contract medical services company IQnovate (NSX:IQN) start strong, but then pare some of their early gains, during the first day of public trading.
Compumedics wins $1m EEG deal
15 December, 2011 by Dylan Bushell-EmblingCompumedics (ASX:CMP) has picked up a deal to supply an EEG system to the Yale School of Medicine.
Government must do more to promote ethical standards in the promotion of health sector products: IVD Australia
13 December, 2011 by Tim DeanIVD Australia has expressed disappointment that the Therapeutic Goods Administration's new blueprint on regulation of the promotion of therapeutic goods doesn't do enough to raise ethical standards in the industry.
Phylogica partnership with Pfizer hits first milestone
13 December, 2011 by Tim DeanDrug discovery company Phylogica (ASX:PYC) has received its first milestone payment from a collaboration with Pfizer to discover novel peptide-based vaccines.
Government about to release $1.2 billion cleantech program for manufacturers
13 December, 2011 by AusBiotechRegistrations of interest are open now for three components of the Government's soon-to-be-released $1.2 billion Clean Technology Program.
Greg Combet takes over as Minister for Innovation
12 December, 2011 by Tim DeanA cabinet reshuffle has seen Greg Combet take over as Innovation Minister from Kim Carr, who has been demoted to the outer ministry.
DSM Biologics and AIBN partner to open biologics facility in Queensland
09 December, 2011 by Tim DeanDutch CMO DSM Biologics has signed a MoU with the Australian Institute for Bioengineering and Nanotechnology to open Australia’s largest biologics facility in Queensland.
Nanopatch wins The Australian Innovation Challenge
09 December, 2011 by Tim DeanThe needle-free vaccination technology by Vaxxas has won the overall award at the inaugural The Australian Innovation Challenge.
CSL partners with NIH for CMV trial in pregnant women
08 December, 2011 by Tim DeanCSL will contribute $2.5 million of immunoglobulin to an NIH-led trial to combat cytomegalovirus (CMV) in pregnant women to prevent congenital CMV in infants.
AVCAL calls for continued govt support for Innovation Investment Fund
08 December, 2011 by Tim DeanThe Australian Private Equity and Venture Capital Association welcomes the government's $100m funding to the Innovation Investment Fund but calls for continued policy commitment.
Commercialisation grants receive overhaul
08 December, 2011 by Staff WritersEarly Stage Commercialisation grants no longer have to be repaid and larger companies can now apply for the grants.
AusBiotech WA Committee welcomes new additions
08 December, 2011 by AusBiotechAusBiotech has welcomed two new appointments to the West Australian Branch Committee and named the new Chair, Mr Brian Leedman.
Strong results from Biotron HCV trial
08 December, 2011 by Dylan Bushell-EmblingNearly 90% of patients treated with Biotron's (ASX:BIT) Hepatitis C treatment candidate demonstrated a complete EVR at three month follow-up.
Govt tips extra $100m into innovation VC fund
08 December, 2011 by Dylan Bushell-EmblingAustralian biotechs will have access to a slice of $200m in startup funding, from VC firms applying for the latest tranche of the government's Innovation Investment Fund.
